No Data
CytoDyn Phase 2 Study of Leronlimab Cleared by FDA
CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies With SMC Laboratories
CYTODYN INC | 10-Q: Q1 2025 Earnings Report
Press Release: CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
Express News | Cytodyn Appoints DR. Max Lataillade as Senior Vice President and Head of Clinical Development
CytoDyn Announces Abstract That Highlights Leronlimab's Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques
No Data
No Data